Endoscopy 2010; 42(2): 93-97
DOI: 10.1055/s-0029-1243856
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Diagnostic accuracy of esophageal capsule endoscopy versus conventional upper digestive endoscopy for suspected esophageal squamous cell carcinoma

D.  Heresbach1 , E.  Leray2 , P.  N.  d’Halluin1 , F.  Cholet3 , M.  G.  Lapalus10 , M.  Gaudric4 , E.  Ben Soussan5 , J.  L.  Gaudin6 , K.  Vahedi7 , V.  Quentin8 , B.  Filoche9 , J.  C.  Saurin6 , S.  Chaussade4 , T.  Ponchon10
  • 1Service des Maladies de l’Appareil Digestif, CHU Pontchaillou, Rennes, France
  • 2Service d’Epidémiologie et de Santé Publique CHU Pontchaillou, Rennes, France
  • 3Service d’Hépato-Gastroentérologie, CHU La Cavale Blanche, Brest, France
  • 4Service d’Hépato-Gastroentérologie, AP-HP Hôpital Cochin, Paris, France
  • 5Service d’Hépato-Gastroentérologie, CHU Charles Nicolle, Rouen, and Service d’Hépato-Gastroentérologie, Clinique de l’Alma, Paris, France
  • 6Service d’Hépato-Gastroentérologie, HCL Centre Hospitalier Lyon Sud, Pierre-Bénite, France
  • 7Service d’Hépato-Gastroentérologie, AP-HP Hôpital Lariboisière, 75475 Paris, France
  • 8Service d’Hépato-Gastroentérologie, CHU Angers, Angers, France
  • 9Service d’Hépato-Gastroentérologie, Hôpital Saint Philibert, Lomme, France
  • 10Service d’Hépato-Gastroentérologie, HCL Hôpital Edouard Herriot, Lyon, France
Further Information

Publication History

submitted 5 June 2009

accepted after revision 26 October 2009

Publication Date:
05 February 2010 (online)

Background and study aim: A video capsule similar to that used in small-bowel capsule endoscopy is now available for esophageal exploration. The aim of our study was to compare the accuracy of upper endoscopy (esophageal gastroduodenoscopy [EGE]) with esophageal capsule endoscopy (ECE) in patients at risk of esophageal squamous cell cancer (SCC).

Patients and methods: 68 patients at risk of SCC secondary to a history of head and neck neoplasia were included in this comparison of techniques for detecting SCC and dysplasia. ECE was done using the first generation Pillcam ESO and EGE was performed in accordance with the usual practice of each center, followed by examination with 2 % Lugol staining and biopsy of unstained areas (39 neoplasia comprising 5 low grade dysplasia, 8 high grade dysplasia and 26 SCC).

Results: Compared with EGE with and without Lugol staining, the sensitivities of ECE for neoplasia diagnosis were 46 % and 54 %, respectively. On a per-patient basis, the sensitivity, specificity, and positive and negative predictive value of ECE were 63 %, 86 %, 77 % and 76 %, respectively, compared with EGE without staining, and 61 %, 86 %, 77 % and 73 % compared with EGE with iodine staining. Neither the ECE transit time nor the distance between the esopharyngeal line and the neoplastic lesion differed between the 21 false-negative and 18 true-positive cases diagnosed by ECE; the only difference was a smaller median diameter among false negatives (P < 0.001).

Conclusion: In a cohort at high risk for esophageal SCC, ECE is not sensitive enough to diagnose neoplastic lesions.

References

  • 1 Jemal A, Thomas A, Murray T, Thun M. Cancer statistics.  CA Cancer J Clin. 2002;  52 23-47
  • 2 Li K, Yu P. Food groups and risk of esophageal cancer in Chaoshan region of China: a high-risk area of esophageal cancer.  Cancer Invest. 2003;  21 237-240
  • 3 Remontet L, Esteve J, Bouvier A M. et al . Cancer incidence and mortality in France over the period 1978 – 2000.  Rev Epidemiol Sante Publique. 2003;  51 3-30
  • 4 Faivre J. Variation in survival of patients with digestive tract cancers in Europe, 1978 – 1989.  Eur J Cancer Prev. 2001;  10 173
  • 5 Laccourreye O, Veivers F D, Hans S. et al . Metachronous second primary cancers after successful partial laryngectomy for invasive squamous cell carcinoma of the true vocal cord.  Ann Otol Rhinol Laryngol. 2002;  111 204-209
  • 6 Licciardello J TW, Spitz M R, Hong W K. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus and lung.  Int J Radiat Oncol Biol Phys. 1989;  17 467-476
  • 7 Eliakim R, Yassin K, Shlomi I. et al . A novel diagnostic tool for detecting oesophageal pathology: The PillCam oesophageal video capsule.  Aliment Pharmacol Ther. 2004;  20 1083-1089
  • 8 Eliakim R, Sharma V K, Yassin K. et al . A prospective study of the diagnostic accuracy of PillCam ESO esophageal capsule endoscopy versus conventional upper endoscopy in patients with chronic gastroesophageal reflux diseases.  J Clin Gastroenterol. 2005;  39 572-578
  • 9 Galmiche J P, Sacher-Huvelin S, Coron E. et al . Screening for esophagitis and Barrett’s esophagus with wireless esophageal capsule endoscopy: a multicenter prospective trial in patients with reflux symptoms.  Am J Gastroenterol. 2008;  103 538-545
  • 10 Lin O S, Schembre D B, Mergener K. et al . Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett’s esophagus in patients with chronic gastroesophageal reflux.  Gastrointest Endosc. 2007;  65 577-583
  • 11 Sharma P, Wani S, Rastogi A. et al . The diagnostic accuracy of esophageal capsule endoscopy in patients with gastroesophageal reflux disease and Barrett’s esophagus: a blinded, prospective study.  Am J Gastroenterol. 2008;  103 525-532
  • 12 Meyer V, Burtin P, Bour B. et al . Endoscopic detection of early oesophageal cancer in a high-risk population: does lugol staining improve videoendoscopy?.  Gastrointest Endosc. 1997;  45 480-484
  • 13 Fagundes R B, de Barros S G, Putten A C. et al . Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.  Endoscopy. 1999;  31 281-285
  • 14 Misumi A, Harada K, Murakami A. et al . Role of Lugol dye endoscopy in the diagnosis of early esophageal cancer.  Endoscopy. 1990;  22 12-16
  • 15 Dubuc J, Seyrig J A, Barbier J P. et al . Endoscopic screening for esophageal squamous cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers.  Endoscopy. 2006;  38 690-695
  • 16 Munoz-Navas M A. Esophageal capsule endoscopy.  World J Gastroenterol. 2008;  14 5254-5260
  • 17 Gralnek I M, Rabinovitz R, Afik D. et al . A simplified ingestion procedure for esophageal capsule endoscopy: initial evaluation in healthy volunteers.  Endoscopy. 2006;  38 913-918
  • 18 Scherübl H, von Lampe B, Faiss S. et al . Screening for oesophageal neoplasia in patients with head and neck cancer.  Br J Cancer. 2002;  86 239-243
  • 19 Li K, Yu P. Food groups and risk of esophageal cancer in Chaoshan region of China: a high-risk area of esophageal cancer.  Cancer Invest. 2003;  21 237-240
  • 20 Gehanno P. Cancers associated with cancer of the esophagus.  Rev Prat. 1999;  49 1177-1179
  • 21 Makuuchi H, Machimura T, Shimada H. et al . Endoscopic screening for esophageal cancer in 788 patients with head and neck cancers.  Tokai J Exp Clin Med. 1996;  21 139-145
  • 22 Muto M, Hironaka S, Nakane M. et al . Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.  Gastrointest Endoscopy. 2002;  56 517-521
  • 23 Narayana A, Vaughan A T, Fisher S G. et al . Second primary tumors in laryngeal cancer: results of long-term follow-up.  Int J Radiat Oncol Biol Phys. 1998;  42 557-562
  • 24 Dikshit R P, Boffetta P, Bouchardy C. et al . Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma.  Cancer. 2005;  103 2326-2333
  • 25 Cooper J S, Pajak T F, Rubin P. et al . Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.  Int J Radiat Oncol Biol Phys. 1989;  17 449-456
  • 26 Morita M, Araki K, Saeki H. et al . Risk factors for multicentric occurrence of carcinoma in the upper aerodigestive tract: Analysis with a serial histologic evaluation of the whole resected-esophagus including carcinoma.  J Surg Oncol. 2003;  83 216-221
  • 27 Yokoyama A, Kumagai Y, Yokoyama T. et al . Health risk appraisal models for mass screening for esophageal and pharyngeal cancer: an endoscopic follow-up study of cancer-free Japanese men.  Cancer Epidemiol Biomarkers Prev. 2009;  18 651-655
  • 28 Hirota W K, Zuckerman M J, Adler D G. et al . Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract.  Gastrointest Endosc. 2006;  63 570-580
  • 29 ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract.  Gastrointest Endosc. 2006;  63 570-580
  • 30 Allum W H, Griffin S M, Watson A. et al., on behalf of the Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology, and the British Association of Surgical Oncology . Guidelines for the management of oesophageal and gastric cancer.  Gut. 2002;  50 Suppl V v1-v23
  • 31 Yokoyama A, Ohmori T, Makuuchi H. et al . Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining.  Cancer. 1995;  76 928-934
  • 32 Ban S, Toyonaga A, Harada H. et al . Iodine staining for early endoscopic detection of esophageal cancer in alcoholics.  Endoscopy. 1998;  30 253-257
  • 33 Froelicher P, Miller G. The European experience with esophageal cancer limited to the mucosa and submucosa.  Gastrointest Endosc. 1986;  32 88-90
  • 34 Wang G Q, Jiao G G, Chang F B. et al . Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening.  Ann Thorac Surg. 2004;  77 1740-1744
  • 35 Shimizu Y, Omori T, Yokoyama A. et al . High-grade intra-epithelial neoplasia turns pink within a few minutes. Endoscopic diagnosis of early squamous neoplasia of the esophagus with iodine staining.  J Gastroenterol Hepatol. 2008;  23 546-550
  • 36 Yoshida T, Inoue H, Usui S. et al . Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions.  Gastrointest Endosc. 2004;  59 288-295
  • 37 Ponchon T, Lapalus M G, Saurin J C. et al . Could narrow band imaging replace lugol staining for the detection of esophageal squamous cell carcinoma?.  Gastrointesinal Endoscopy. 2007;  65 AB343
  • 38 Chiu P W, Cheung F K, Tsang R K. et al . Narrow band imaging against conventional lugol chromoendoscopy for detection of superficial esophageal neoplasia in high risk patients: a prospective comparartive study.  Gastrointest Endosc. 2007;  65 AB332
  • 39 Muto M, Saito Y, Ohmori T. et al . Multicenter prospective randomized study on the detection and diagnosis of superficial squamous cell carcinoma by back to back endoscopic examination with NBI and white light observation.  Gastrointest Endosc. 2007;  65 AB110
  • 40 Gralnek I M, Adler S N, Yassin K. et al . Detecting esophageal disease with second-generation capsule endoscopy: initial evaluation of the PillCam ESO 2.  Endoscopy. 2008;  40 275-279
  • 41 Koslowsky B, Jacob H, Eliakim R. et al . PillCam ESO in esophageal studies: improved diagnostic yield of 14 frames per second (fps) compared with 4 fps.  Endoscopy. 2006;  38 27-30
  • 42 Tincani A J, Brandalise N, Altemani A. et al . Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2 % Lugol dye solution in patients with head and neck cancer.  Head Neck. 2000;  22 170-174
  • 43 Anani P A, Gardio L D, Savary M. et al . An extensive morphological and comparative study of clinically early and obvious squamous cell carcinoma of the esophagus.  Pathol Res Pract. 1991;  187 214-219
  • 44 Kuwano H, Watanabe M, Sadanaga N. et al . Squamous epithelial dysplasia associated with squamous cell carcinoma of the oesophagus.  Cancer Lett. 1993;  72 141-147
  • 45 Wang G Q, Jiao G G, Chang F B. et al . Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening.  Ann Thorac Surg. 2004;  77 1740-1744

D. HeresbachMD, PhD 

Service des Maladies de l’Appareil Digestif, CHU Pontchaillou

35033 Rennes Cedex 09
France

Fax: +33-2-99284189

Email: denis.heresbach@chu-rennes.fr

    >